Risk Factors of Hypertension among Type 2 Diabetic Patients in Imo state, South East of Nigeria

Main Article Content

Ugonma, Winnie Dozie
Nnenna, Vivian Okonkwo
Okwuchi, Blessed Nworuh
Somtochukwu, Mercy Orji
Chidozie Joakin Nwaokoro
Ikechukwu, Nosike Simplicius Dozie

Abstract

Background: Hypertension is among the important causes of non-communicable disease burden worldwide. It has raised public health concerns in both developed and developing nations. It mostly occurs in patients with diabetes and the prevalence depends on duration, type and age of the patient. The study aimed at determining the risk factors of hypertension among type 2 diabetic patients in Imo State, Nigeria.

Methods: A hospital-based descriptive survey design involving 50 patients attending hospital was used. Structured questionnaire complemented with interview schedule was used to collect data from the respondents. Data were analyzed using frequency and mean score. Hypotheses were tested using Chi-square at 5% significance level.

Results: The result showed that the majority (70.0%) of the patients was hypertensive, 54.0% of the patients used dietary control and drugs in the treatment of the diseases. Furthermore, it was found that 54.0% ate salty foods always, 58.0% of the patients added extra table salt in their meals, 54.0% ate canned foods and 82.0% took sugary drinks always. It was also found that 66.0% ate always from restaurants and 58.0% ate more of starchy foods. The result further showed that 74.0% of the patients avoided physical exercise and 70.0% indicated that doing stress works made them get anxious. Eighty percent of the patients had hypertension in their family history and the 74.0% indicated it was their brother/sister. The X2 result showed a significantly association between family history of hypertension and type 2 diabetes X2(121, N = 50) = 187, p = 0.000. It was also found that dietary pattern was significantly associated with risk of type 2 diabetes X2(121, N = 50) = 187, p = 0.000.

Conclusion: Dietary pattern and family history of hypertension were significantly associated with type 2 diabetes. It was recommended that sensitization campaigns be organized to educate women on the effect of diets on diabetes. Also, family history of hypertension should be ascertained from patients to ensure early detection and treatment of diabetes.

Keywords:
Risk factors, type 2 diabetes, hypertensive patients, cardiovascular disease, Nigeria.

Article Details

How to Cite
Dozie, U. W., Okonkwo, N. V., Nworuh, O. B., Orji, S. M., Nwaokoro, C. J., & Dozie, I. N. S. (2020). Risk Factors of Hypertension among Type 2 Diabetic Patients in Imo state, South East of Nigeria. Asian Journal of Medicine and Health, 18(10), 65-72. https://doi.org/10.9734/ajmah/2020/v18i1030253
Section
Original Research Article

References

Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Almazroa MA, Alvarado M, Anderson RH, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collor S, Murray CJL. Global and regional mortality from 235 causes of death for age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2095–2128.

Alexander MR. What is the global prevalence of hypertension (high blood pressure)? Medscape, June 21; 2019.

World Health Organization, WHO. Physical activity for patients with hypertension. A non-communicable disease education manual for primary healthcare professionals and patients. World Health Organization, Western Pacific Region; 2017.

Lim SS, Vos T, Flaxman AD, Danaei G. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors clusters in 21 regions, 1990 – 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–2260.

World Health Organization, WHO. Causes of death 2008 (online database); 2013. Available:https://www.who.int/healthinfo/global_burden_disease/cod_2008_sources_methods.pdf

Fuentes R, Ilmaniemi N, Laurikainen E, Tuomilehto J, Nissinen A. (). Hypertension in developing economies: A review of population-based studies carried out from 1980 – 1998. Journal of Hypertension. 2000;18:521-529. DOI: http://dx.doi.org/10.1097/00004872-2000018050 - 00003PMID: 10826553

Ibrahim MM, Damasceno A. Hypertension in developing countries. Lancet. 2012;380: 611–619.

Seedat YK. Hypertension in developing nations in sub-Saharan Africa. Journal of Human Hypertension. 2000;14(9):3–11.

Van de Vijver S, Akinyi h, Oti S, Olajide A, Agyemang C, Aboderin I, Kyobutungi C. Status report on hypertension in Africa – consultative review for the 6th Session of the African Union Conference of Ministers of Health on NCDs. Pan African Medical Journal. 2013;16:38. DOI: 10.11604/pamj.2013.16.38.3100

Anwer Z, Sharma PK, Garg VK, Kumar N, Kumari A. (). European Review for Medical and Pharmacological Science. 2011;15:1256–1263.

Bakris GL, Barnhill BW, Sadler R. Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection. Kidney International. 2012;41:912–919.

De Boer IH, Bangalore S, Benetos A, Davis AM, Michos ED, Muntner P, Rossing P, Zoungas S, Bakris G. Diabetes and hypertension: A position statement by the American Diabetes Association, Diabetes care. 2017;40(supply.1):S2. Available:https://doi.org/10.2337/dc17.S001

Olack B, Wabire-Mangen F, Smeeth L, Montgomery JM, Kiwanuka N, Breiman RF. Risk factors of hypertension among adults aged 35 – 64 years living in urban slum Nairobi, Kenya. Public Health. 2015;15:1251. DOI: 10.1186/s12889-015-2610-8

Standley PR, Ali S, Bapna C, Sowers JR. Increased platelet cytosolic calcium responses to low density and without hypertension. American Journal of Hypertension, 2003;6:938–943.

Stern MP. Do non-insulin-dependent diabetes mellitus and cardiovascular disease share common antecedents? Annals of Internal Medicine. 1996;124:110–116.

Sowers JR, Zemel M. clinical implications of hypertension in the diabetic patient. American Journal of Hypertension. 2010;3:415–424.

Keamy PM, Whelton M, Raynolds K. Global burden of hypertension analysis of worldwide data. Lancet. 2015;265:217–223.

Mawaw PM, Yav T, Mukuku O, Lukanka O, Kazadi PM, Tambwe D, Omba J, Kakoma J, Bangs MJ, Luboya OS. Prevalence of obesity, diabetes mellitus, hypertension and associated risk factors in a minning workforce, democratic Republic of Congo. Pan African Medical Journal. 2017;28:282. DOI: 10.11604/pmj.2017.28.282.14361

Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalanen H, PIllannne-Parikka P, Kinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen, V., Aunola, S. Prevention of Type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. The New England Journal of Medicine. 2001;344:1343–1350.

Unadike BC, Ereggie A, Ohwovoriole AE. Prevalence of hypertension amongst persons with diabetes mellitus in Benin City, Nigeria. Nigerian Journal of Clinical Practice. 2011;14(3):300–302.

Hashemizadeh H, Dorari S, Sarvelayati DS. Hypertension and type 2 diabetes: A cross-sectional study in hospitalized patients in Quchan, Iran. Iranian Journal of Diabetes and Obesity. 2013;5(1):21–26.

Kotchen T. Obesity-related hypertension: epidemiology, pathophysiology and clinical management. American Journal of Hypertension. 2010;23(11):1170–1178. Available:https://doi.org/10.1038/ajh.2010.172

World Health Organization, WHO. Non-communicable disease education manual for primary health care professionals and patients. WHO; 2017.

Ranasinghe P, Cooray DN, Jawawardena R, Katulanda P. The influence history of hypertension on disease prevalence and associated metabolic risk factors among Sri Lankan adults. BMC Public Health. 2015;15:576.DOI: 10.1186/s12889-015-1927 – 7

Barlassina C, Lanzani C, Manunta P, Bianachi G. Genetics of essential hypertension: Rom family to genes. Journal of American Society of Nephrology. 2002;13(Suppl. 3):S155–S164.

Carretero OA, Oparil S. Essential hypertension. Part I: definition and etiology. Circulation. 2000;101(3):329–335. DOI: 10.1161/01.CIR.101.3.329

Corvol P, Juenemaitre X, Charru A, Soubrier F. Can the genetic factors help in the treatment of systemic hypertension? The case of the renin-hypertension in adolescents. American Journal of Cardiology, 1992;70(12):14D–20D. DOI: 10.1016/0002-9149(92)90267 – 3

Simsolo RB, Pomo NM, Rabinovich L, Bananno M, Grunfeld B. (). Family history of essential hypertension versus obesity as risk factors for hypertension in adolescents. American Journal of Hypertension. 1999;12(3):260–263.

Goldstein I, Shapiro D, Weiss R. How family history and risk factors for hypertension relate to ambulatory blood pressure in healthy adults. Journal of Hypertension. 2008;26(2):276–283. DOI: 10.1097/HJH.0b013e3282fi5c27

Khanna N, Sharma RS, Sidhu RS. A study of the basic and derived anthropometric indices among healthy adults (20 – 30 years of age) of Amristar city (Punjab) having family history of hypertension. International Journal of Biology and Medical Resource. 2011;2(3):743–746.

Zafar SN, Gowani SA, Irani FA, Isahq M. Awareness of risk factors presenting features and complications of hypertension amongst hypertensives and normotensives. Journal of Paskistani Medical Association, 2008;288(15):1882–1888.

Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, Rocella EJ, Stout R, Vallbona Winston MC, Karimbakas J. Primary prevention of hypertension: Clinical and public health advisory from the National High Blood Pressure Education Program. Journal of American Medical Association. 2002;288(15):1882–1888.